Kevin Hartz’s A* just closed its third fund with $450 million
Early-stage venture firm A* Capital just took the wraps off its $450 million Fund III.
Early-stage venture firm A* Capital just took the wraps off its $450 million Fund III.
Bindwell applies AI drug discovery techniques to invent new pesticide molecules.